These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 24750201)

  • 1. Gastrointestinal: bevacizumab-induced reversible posterior leukoencephalopathy syndrome in patient with rectal cancer.
    Goto N; Mimura J
    J Gastroenterol Hepatol; 2014 May; 29(5):895. PubMed ID: 24750201
    [No Abstract]   [Full Text] [Related]  

  • 2. Neoadjuvant capecitabine and oxaliplatin (XELOX) combined with bevacizumab for high-risk localized rectal cancer.
    Hasegawa J; Nishimura J; Mizushima T; Miyake Y; Kim HM; Takemoto H; Tamagawa H; Noura S; Fujii M; Fujie Y; Kato T; Miwa H; Takemasa I; Ikeda M; Yamamoto H; Sekimoto M; Nezu R; Doki Y; Mori M
    Cancer Chemother Pharmacol; 2014 May; 73(5):1079-87. PubMed ID: 24595805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of bronchiolitis obliterans organizing pneumonia with platinum-based chemotherapy for metastatic rectal cancer.
    Fekrazad MH; Eberhardt S; Jones DV; Lee FC
    Clin Colorectal Cancer; 2010 Jul; 9(3):177-8. PubMed ID: 20643623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Advances in research on capecitabine as adjuvant treatment for colon cancer after radical resection].
    Zhang SZ
    Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):801-3. PubMed ID: 21223682
    [No Abstract]   [Full Text] [Related]  

  • 5. Maintenance therapy for colorectal cancer.
    Marshall JL
    Oncology (Williston Park); 2014 Apr; 28(4):322, 324. PubMed ID: 24839806
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemotherapy or no chemotherapy in clear margins after neoadjuvant chemoradiation in locally advanced rectal cancer: CHRONICLE. A randomised phase III trial of control vs. capecitabine plus oxaliplatin.
    Glynne-Jones R; Meadows H; Wood W
    Clin Oncol (R Coll Radiol); 2007 Jun; 19(5):327-9. PubMed ID: 17434299
    [No Abstract]   [Full Text] [Related]  

  • 7. [A case of necrotizing fasciitis developed in a patient with recurrent rectal cancer treated with chemotherapy].
    Shimada A; Nakamura T; Ishii M; Chiba N; Ishikawa S; Arisawa Y; Hashimoto M
    Gan To Kagaku Ryoho; 2013 May; 40(5):663-5. PubMed ID: 23863596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bevacizumab-induced reversible posterior leukoencephalopathy syndrome in a patient with metastatic colorectal cancer].
    Miyamoto S
    Nihon Shokakibyo Gakkai Zasshi; 2014 Apr; 111(4):743-7. PubMed ID: 24769463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current role of bevacizumab in colorectal cancer.
    Saltz L
    Clin Adv Hematol Oncol; 2009 Jun; 7(6):375-6. PubMed ID: 19606071
    [No Abstract]   [Full Text] [Related]  

  • 10. Neoadjuvant chemotherapy in MRI-staged rectal cancer.
    Glynne-Jones R
    Lancet Oncol; 2010 Mar; 11(3):213-4. PubMed ID: 20202602
    [No Abstract]   [Full Text] [Related]  

  • 11. [A case report of pathologically complete response of locally advanced rectal cancer after neoadjuvant chemoradiotherapy with XELOX and bevacizumab].
    Miyazawa T; Ebe K; Fujita N; Koide N; Honma K; Ikarashi T
    Gan To Kagaku Ryoho; 2012 Jun; 39(6):1001-3. PubMed ID: 22705702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative sequential short-term radiotherapy plus chemotherapy can induce complete remission in T3N2 rectal cancer.
    Widder J; Herbst F; Scheithauer W
    Acta Oncol; 2005; 44(8):921-3. PubMed ID: 16332603
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of bevacizumab-based preoperative radiochemotherapy in patients with locally advanced rectal cancer on surgery-associated spectrum of complications.
    Dellas K; Buller J; Görtz GJ; Richter M; Höhler T; Arnold D; Keck T; Dunst J; Zühlke H
    Ann Surg Oncol; 2014 Apr; 21(4):1352-60. PubMed ID: 24306667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of locally advanced colorectal cancer with abscess responding to 5-fluorouracil, leucovorin, and oxaliplatin plus bevacizumab].
    Kuwabara H; Watanabe S; Liu B; Mitsuoka A; Sanada T; Nakajima K; Goseki N
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2032-4. PubMed ID: 24394003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible leukoencephalopathy with stroke-like presentation in a patient with 5-dihydropyrimidine dehydrogenase deficiency treated with continuous 5-fluorouracil infusion.
    Li J; Lee JJ; Chu E; Baehring JM
    Clin Colorectal Cancer; 2012 Sep; 11(3):215-7. PubMed ID: 22410472
    [No Abstract]   [Full Text] [Related]  

  • 16. Short time infusion of bevacizumab in combination with 5FU-based chemotherapy as first-line therapy in a non-selective patient group with metastatic colorectal cancer.
    Dohn LH; Jensen BV; Larsen FO
    Acta Oncol; 2010 Apr; 49(3):395-6. PubMed ID: 20001495
    [No Abstract]   [Full Text] [Related]  

  • 17. Oxaliplatin-induced thrombotic thrombocytopenic purpura: case report and literature review.
    Niu J; Mims MP
    J Clin Oncol; 2012 Nov; 30(31):e312-4. PubMed ID: 22987080
    [No Abstract]   [Full Text] [Related]  

  • 18. Bevacizumab in metastatic colorectal cancer: a left intracardiac thrombotic event.
    Roncalli J; Delord JP; Galinier M; Massabuau P; Lescure M; Fauvel JM; Azria D
    Ann Oncol; 2006 Jul; 17(7):1177-8. PubMed ID: 16524976
    [No Abstract]   [Full Text] [Related]  

  • 19. [A case of an ulcer of the sigmoid colon during chemotherapy with FOLFOX4 and bevacizumab for recurrence of rectal carcinoma].
    Okuya K; Mizushima Y; Hirata K
    Gan To Kagaku Ryoho; 2013 Jan; 40(1):107-9. PubMed ID: 23306930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining capecitabine and bevacizumab in metastatic breast cancer: a comprehensive review.
    Miles D; Zielinski C; Martin M; Vrdoljak E; Robert N
    Eur J Cancer; 2012 Mar; 48(4):482-91. PubMed ID: 22257791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.